Zobrazeno 1 - 2
of 2
pro vyhledávání: '"I S Bulavina"'
Autor:
I V Poddubnaya, M R Lichinitser, S A Tyulyandin, V A Gorbunova, V V Ptushkin, M A Abramov, N S Besova, L V Bolotina, I S Bulavina, O A Gladkov, I S Davidenko, L G Zhukova, I A Koroleva, V O Korolenko, G M Manikhas, A V Snegovoy, Yu I Tyukalov, R Sh Khasanov, L N Shigapova
Publikováno v:
Современная онкология, Vol 13, Iss 2, Pp 50-56 (2011)
Externí odkaz:
https://doaj.org/article/6988344d7af547529dcd0ffe010d684e
Autor:
I. S. Bulavina, S. Y. Krasilnikova
Publikováno v:
Тазовая хирургия и онкология, Vol 0, Iss 1, Pp 27-30 (2015)
Bevacizumab in combination with standard chemotherapy (CT) in 1st line metastatic colorectal cancer (mCRC) settings prolongs median overall survival to 20,3 months. Data of observational cohort programs suggests that bevacizumab therapy beyond diseas
Externí odkaz:
https://doaj.org/article/f6074f97e98f4da7b9a476c70a782890